Global Pharmaceuticals & Biotech Healthy potentially undervalued

High Tide

Market Cap: CA$261.0m

Engages in the cannabis retail business in Canada, the United States, and internationally.

United Therapeutics

Market Cap: US$21.9b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Kissei Pharmaceutical

Market Cap: JP¥159.8b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Hypera

Market Cap: R$15.1b

Operates as a pharmaceutical company in Brazil.

Arcutis Biotherapeutics

Market Cap: US$3.2b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

CorMedix

Market Cap: US$592.3m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Innovent Biologics

Market Cap: HK$149.7b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥13.0b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Supernus Pharmaceuticals

Market Cap: US$2.7b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Kuros Biosciences

Market Cap: CHF 887.8m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

UCB

Market Cap: €42.2b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Yunnan Baiyao GroupLtd

Market Cap: CN¥93.3b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

Hugel

Market Cap: ₩2.6t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €196.2m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Bavarian Nordic

Market Cap: DKK 13.7b

Develops, manufactures, and supplies life-saving vaccines.

Diaceutics

Market Cap: UK£123.6m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Prestige Consumer Healthcare

Market Cap: US$2.5b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Ardelyx

Market Cap: US$1.2b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Dong-E-E-Jiao

Market Cap: CN¥35.4b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Shionogi

Market Cap: JP¥2.5t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Fennec Pharmaceuticals

Market Cap: US$333.1m

Operates as a commercial stage biopharmaceutical company in the United States.

Journey Medical

Market Cap: US$178.1m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Amoy Diagnostics

Market Cap: CN¥6.8b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

Decibel Cannabis

Market Cap: CA$57.7m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Dong-A ST

Market Cap: ₩344.6b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Perrigo

Market Cap: US$1.5b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Exagen

Market Cap: US$113.1m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

China Resources Pharmaceutical Group

Market Cap: HK$30.6b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

United Laboratories International Holdings

Market Cap: HK$17.8b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Daewoong Pharmaceutical

Market Cap: ₩1.3t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

Verastem

Market Cap: US$500.0m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

H. Lundbeck

Market Cap: DKK 39.0b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Avantor

Market Cap: US$9.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Pacira BioSciences

Market Cap: US$1.1b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.